Gender specificity of a genetic variant of angiotensin-converting enzyme and risk of coronary artery disease

被引:0
|
作者
Negar Firouzabadi
Nader Tajik
Ehsan Bahramali
Hooman Bakhshandeh
Mohsen Maadani
Massoumeh Shafiei
机构
[1] School of Medicine,Department of Pharmacology
[2] Tehran University of Medical Sciences,Division of Transplant Immunology and Immunogenetics, Department of Immunology
[3] School of Medicine,Department of Cardiology and Cardiovascular Research
[4] Tehran University of Medical Sciences,Department of Epidemiology and Biostatistics
[5] Rajaee Heart Center,undefined
[6] Tehran University of Medical Sciences,undefined
[7] Rajaee Heart Center,undefined
[8] Tehran University of Medical Sciences,undefined
来源
Molecular Biology Reports | 2013年 / 40卷
关键词
Renin-angiotensin system; Angiotensin-converting enzyme; Coronary artery disease; Genetic polymorphism; Single nucleotide polymorphism;
D O I
暂无
中图分类号
学科分类号
摘要
Etiological factors for coronary artery disease (CAD) involve a wide range of gene and environmental interactions. One of the systems being implicated in the pathophysiology of CAD is the renin-angiotensin system (RAS). However, the genetic polymorphisms of this system have not been widely studied in Iranian patients diagnosed with CAD. The aim of this study was to assess the relationship between six gene polymorphisms of RAS components and CAD in a sample of Iranian population. A total of 374 participants were enrolled in a case/control study. The presence of CAD was determined by coronary angiography. Genotyping of six RAS gene polymorphisms was performed using a modified PCR–RFLP method. Our results revealed, for the first time, a significant independent association of angiotensin-converting enzyme (ACE) A-240T polymorphism and incidence of CAD among Iranian women (P = 0.005, OR = 20.4, 95 % CI = 2.49–41.2). There has also been a significant difference in genotype distribution of ACE A-240T (P = 0.008) and angiotensin II receptor type 2 C3123A polymorphism (P = 0.032) in Iranian female participants. In conclusion, TT genotype of ACE A-240T seems to be a genetic risk factor for CAD in Iranian women.
引用
收藏
页码:4959 / 4965
页数:6
相关论文
共 50 条
  • [31] The effect of angiotensin-converting enzyme inhibitor exposure on coronary artery bypass grafting
    Seese, Laura
    Sultan, Ibrahim
    Wang, Yisi
    Gleason, Thomas
    Thoma, Floyd
    Kilic, Arman
    JOURNAL OF CARDIAC SURGERY, 2020, 35 (01) : 58 - 65
  • [32] Chronic kidney disease - Tipping the scale to the benefit of angiotensin-converting enzyme inhibitors in patients with coronary artery disease
    McCullough, Peter A.
    CIRCULATION, 2006, 114 (01) : 6 - 7
  • [33] The Renin-Angiotensin-Aldosterone System: Approaches to Guide Angiotensin-Converting Enzyme Inhibition in Patients with Coronary Artery Disease
    Brugts, J. J.
    den Uil, C. A.
    Danser, A. H. J.
    Boersma, E.
    CARDIOLOGY, 2009, 112 (04) : 303 - 312
  • [34] The effect of angiotensin-converting enzyme inhibitors on plasma adipokine levels in normotensive patients with coronary artery disease
    Krysiak, Robert
    Sierant, Marian
    Marek, Bogdan
    Bienek, Radoslaw
    Okopien, Boguslaw
    ENDOKRYNOLOGIA POLSKA, 2010, 61 (03) : 280 - 286
  • [35] Angiotensin converting enzyme gene polymorphism in coronary artery disease: The Indian scenario
    Joseph, A
    Nair, KG
    Ashavaid, TF
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1998, 36 (08) : 621 - 624
  • [36] Association between genetic polymorphism of angiotensin-converting enzyme gene and Parkinson's disease
    Lin, JJ
    Yueh, KC
    Chang, DC
    Lin, SZ
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 (1-2) : 25 - 29
  • [37] Role of Genetic Polymorphism of Angiotensin-Converting Enzyme, Plasminogen Activator Inhibitor-1 and Endothelial Nitric Oxide Synthase in the Prognosis of Coronary Artery Disease
    Zhang, Ai Yuan
    Ji, Xiang Wu
    Zhang, Ai Juan
    Guan, Li Xue
    Huang, Jing
    Wang, Jing Xian
    CARDIOLOGY RESEARCH, 2010, 1 (01) : 8 - 14
  • [38] Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model
    Oemrawsingh, Rohit M.
    Akkerhuis, K. Martijn
    Van Vark, Laura C.
    Redekop, Ken
    Rudez, Goran
    Remme, Willem J.
    Bertrand, Michel E.
    Fox, Kim M.
    Ferrari, Roberto
    Danser, A. H. Jan
    de Maat, Moniek
    Simoons, Maarten L.
    Brugts, Jasper J.
    Boersma, Eric
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (03):
  • [39] Polymorphism and synergism of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) genes in coronary artery disease
    Sakhteh, Maryam
    Poopak, Behzad
    Amirizadeh, Naser
    Shamshiri, Ahmadreza
    Bagheri, Abdolhamid
    Faranoush, Mohammad
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2015, 16 (04) : 1168 - 1174
  • [40] ANGIOTENSIN-I CONVERTING-ENZYME GENOTYPE DD IS A RISK FACTOR FOR CORONARY-ARTERY DISEASE
    BEOHAR, N
    DAMARAJU, S
    PRATHER, A
    YU, QT
    RAIZNER, A
    KLEIMAN, NS
    ROBERTS, R
    MARIAN, AJ
    JOURNAL OF INVESTIGATIVE MEDICINE, 1995, 43 (03) : 275 - 280